Chikungunya Virus Control: is a Vaccine on the Horizon?

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 2014 Aug 19

PMID 25132506

Citations 12

Authors

Ann M Powers

Affiliations

Soon will be listed here.

Citing Articles

Niche and Range Shifts of and Suggest That the Latecomer Shows a Greater Invasiveness.

Nie P, Feng J Insects. 2023; 14(10).

PMID: 37887822 PMC: 10607146. DOI: 10.3390/insects14100810.

Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis.

Claypool A, Brandeau M, Goldhaber-Fiebert J PLoS Negl Trop Dis. 2021; 15(12):e0010086.

PMID: 34965277 PMC: 8752007. DOI: 10.1371/journal.pntd.0010086.

Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development.

Rezza G, Weaver S PLoS Negl Trop Dis. 2019; 13(1):e0006919.

PMID: 30653504 PMC: 6336248. DOI: 10.1371/journal.pntd.0006919.

Diagnostic challenges in chikungunya infection: Report of an atypical presentation.

Craig J, Klowak M, Boggild A Can Commun Dis Rep. 2018; 41(1):6-10.

PMID: 29769914 PMC: 5864422. DOI: 10.14745/ccdr.v41i01a02.

Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.

Auerswald H, Boussioux C, In S, Mao S, Ong S, Huy R Emerg Microbes Infect. 2018; 7(1):13.

PMID: 29410416 PMC: 5837154. DOI: 10.1038/s41426-017-0010-0.

References

Andre F . How the research-based industry approaches vaccine development and establishes priorities. Dev Biol (Basel). 2002; 110:25-9. View

Douglas D, DeRoeck D, Mahoney R, Wichmann O . Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders. PLoS Negl Trop Dis. 2013; 7(3):e2127. PMC: 3597493. DOI: 10.1371/journal.pntd.0002127. View

Soumahoro M, Boelle P, Gauzere B, Atsou K, Pelat C, Lambert B . The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis. 2011; 5(6):e1197. PMC: 3114750. DOI: 10.1371/journal.pntd.0001197. View

Pronker E, Weenen T, Commandeur H, Claassen E, Osterhaus A . Risk in vaccine research and development quantified. PLoS One. 2013; 8(3):e57755. PMC: 3603987. DOI: 10.1371/journal.pone.0057755. View

. West Nile virus and other arboviral diseases--United States, 2012. MMWR Morb Mortal Wkly Rep. 2013; 62(25):513-7. PMC: 4604949. View

Gerardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P . Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis. 2008; 8:99. PMC: 2528011. DOI: 10.1186/1471-2334-8-99. View

Edelman R, Tacket C, Wasserman S, Bodison S, Perry J, Mangiafico J . Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2001; 62(6):681-5. DOI: 10.4269/ajtmh.2000.62.681. View

Fischer M, Staples J . Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014; 63(22):500-1. PMC: 5779358. View

Vazquez-Prokopec G, Chaves L, Ritchie S, Davis J, Kitron U . Unforeseen costs of cutting mosquito surveillance budgets. PLoS Negl Trop Dis. 2010; 4(10):e858. PMC: 2964299. DOI: 10.1371/journal.pntd.0000858. View

10.

Mahoney R, Francis D, Frazatti-Gallina N, Precioso A, Raw I, Watler P . Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil. Vaccine. 2012; 30(32):4892-6. DOI: 10.1016/j.vaccine.2012.02.064. View

11.

Sergon K, Yahaya A, Brown J, Bedja S, Mlindasse M, Agata N . Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg. 2007; 76(6):1189-93. View

12.

Hoke Jr C, Pace-Templeton J, Pittman P, Malinoski F, Gibbs P, Ulderich T . US Military contributions to the global response to pandemic chikungunya. Vaccine. 2012; 30(47):6713-20. DOI: 10.1016/j.vaccine.2012.08.025. View

13.

Akahata W, Yang Z, Andersen H, Sun S, Holdaway H, Kong W . A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med. 2010; 16(3):334-8. PMC: 2834826. DOI: 10.1038/nm.2105. View